<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>18(1)</volume><submitter>Drozdoff L</submitter><funding>Technische Universität München</funding><funding>Deutsche Forschungsgemeinschaft</funding><pubmed_abstract>&lt;h4>Background&lt;/h4>Biologically-based complementary medicines (BB-CAM) including herbs and nutritional supplements are frequently taken by breast- and gynecological cancer patients undergoing systemic therapy. The aim of this study was to analyze the use of these natural CAM methods under systemic therapy.&lt;h4>Methods&lt;/h4>From September 2014 to December 2014 and February 2017 to May 2017 all patients (n= 717) undergoing systemic therapy at the day care unit, Department of Gynecology and Obstetrics, Technical University Munich, Germany, with breast- and/or gynecological cancer were included in this survey. The self-administered 8-item questionnaire was developed to obtain information on complementary medication intake during systemic therapy.&lt;h4>Results&lt;/h4>Among 448 respondents 74.1% report</pubmed_abstract><journal>BMC complementary and alternative medicine</journal><pagination>259</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6154925</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Use of biologically-based complementary medicine in breast and gynecological cancer patients during systemic therapy.</pubmed_title><pmcid>PMC6154925</pmcid><pubmed_authors>Klein E</pubmed_authors><pubmed_authors>Drozdoff L</pubmed_authors><pubmed_authors>Paepke D</pubmed_authors><pubmed_authors>Kiechle M</pubmed_authors></additional><is_claimable>false</is_claimable><name>Use of biologically-based complementary medicine in breast and gynecological cancer patients during systemic therapy.</name><description>&lt;h4>Background&lt;/h4>Biologically-based complementary medicines (BB-CAM) including herbs and nutritional supplements are frequently taken by breast- and gynecological cancer patients undergoing systemic therapy. The aim of this study was to analyze the use of these natural CAM methods under systemic therapy.&lt;h4>Methods&lt;/h4>From September 2014 to December 2014 and February 2017 to May 2017 all patients (n= 717) undergoing systemic therapy at the day care unit, Department of Gynecology and Obstetrics, Technical University Munich, Germany, with breast- and/or gynecological cancer were included in this survey. The self-administered 8-item questionnaire was developed to obtain information on complementary medication intake during systemic therapy.&lt;h4>Results&lt;/h4>Among 448 respondents 74.1% report</description><dates><release>2018-01-01T00:00:00Z</release><publication>2018 Sep</publication><modification>2026-05-06T04:08:24.063Z</modification><creation>2026-04-07T22:15:15.308Z</creation></dates><accession>S-EPMC6154925</accession><cross_references><pubmed>30249217</pubmed><doi>10.1186/s12906-018-2325-3</doi></cross_references></HashMap>